The ECASS III results and the tPA paradox

Int J Stroke. 2009 Feb;4(1):17-8. doi: 10.1111/j.1747-4949.2009.00248.x.
No abstract available

Publication types

  • Review

MeSH terms

  • Clinical Trials as Topic*
  • Fibrinolytic Agents / administration & dosage*
  • Humans
  • Stroke / drug therapy*
  • Time
  • Tissue Plasminogen Activator / administration & dosage*

Substances

  • Fibrinolytic Agents
  • Tissue Plasminogen Activator